Caffeine Completed Phase 1 Trials for Tumors, Solid Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT01517399Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects